Skip to content
Search AI Powered

Latest Stories

Online pharmacy PillTime installs Titan PMR in its new state-of-art facility to boost prescription growth

Online pharmacy PillTime has taken a step to boost its prescription growth by implementing new Patient Medication Record (PMR) system Titan in its state-of-the-art premises.

PillTime moved to new, expanded 26,000sqft premises in Cribbs Causeway on the edge of Bristol earlier this year, where it has also installed state-of-the-art robotics in a bid to significantly enhance future productivity and capacity.


Teething problems over Easter weekend saw PillTime struggling to seamlessly integrate all the new systems and processes while physically moving premises which affected service delivery and customer support.

However, CEO Leighton Humphreys was supported by Tariq Muhammad, CEO of Invatech Health, who is a former community pharmacist and has worked with independent pharmacies around the UK as well as larger online businesses, to integrate Titan into their workflows.

Alongside integration work, Muhammad and his team supported PillTime with necessary design, governance and pharmacy expertise as the company struggled to meet its usual high standards for dispensing medicines to patients.

“We had ambitious plans for our move but things turned out to be more complicated than we had envisaged,” said Humphreys. “So we are extremely grateful to Tariq and his team of pharmacists for the support they provided.

“We thank our customers for sticking with us during this challenging period for our business and we’re looking ahead now. Titan will make a major difference to how we operate and grow, alongside the cutting-edge robotics and innovative pouching system which are unique at this scale.”

Founded in 2016, PillTime currently provides prescription medicines in daily dosage pouches to around 11,000 NHS patients across the UK.

Following the deployment of Titan, it forecasts 900 per cent growth in the next two to three years. It hopes to hit the 100,000 patient mark by the end of 2023 – a figure it says is still ‘only a drop in the ocean’.

Last year Invatech Health announced a further £950,000 loan from Innovate UK, under a programme to support game-changing innovations in the UK’s SME community.

Muhammad, said he was pleased to support PillTime.

“Having established our systems in the community pharmacy sector, we are now enjoying rolling out Titan Enterprise to innovative online pharmacy businesses,” he said, adding: “We’re helping them process prescriptions safely at a speed which is unheard of until now.

“Of course It’s great to be collaborating with another innovative Bristol-based business which is looking to help transform the way that people manage and access their medication.

“Now all systems are fully operational, we are excited to see how PillTime develops over the coming months and years.”

Humphreys said that PillTime’s offering of medication in easy-to-understand pouches provided a solution to several problems, from reducing the requirement for carers and nursing homes, while minimising hospital admissions through medication errors.

“There are far too many instances of medications being properly dispensed but incorrectly taken, leading to people not getting better as they should do,” he said.

“In some parts of the world the pouching system has become standard because it’s foolproof, as long as the patient is fully aware. We want that to happen here, too. Our mission is cost savings to the NHS and a better quality of convenience and level of healthcare. “

More For You

Sigma Conference: "Pharmacists need greater role in integrated care boards," says CPE representative

Prakash Patel was speaking at a panel discussion at the Sigma Conference

Sigma Conference: "Pharmacists need greater role in integrated care boards," says CPE representative

Pharmacists need to be a part of integrated care boards (ICB) to stop GPs from monopolising services based on their needs rather than the needs of the patient, according to Prakash Patel, Community Pharmacy Engaland (CPE) representative for North London.

“The evolution of the NHS should mean there can be no decision of pharmacy without pharmacist,” Patel told delegates at the Sigma Pharmacy Conference in Baku, Azerbaijan on Tuesday.

Keep ReadingShow less
David Webb
David Webb, NHS England's Chief Pharmaceutical Officer
David Webb, NHS England's Chief Pharmaceutical Officer

Sigma Conference: "Community pharmacy ready to make a profound contribution to 10 Year Health Plan," says David Webb

A national community pharmacy prescribing service remains a long-term goal of the government, according to NHS chief pharmaceutical officer, David Webb.

The Labour Party in its election manifesto last year said it would “create a Community Pharmacist Prescribing Service, granting more pharmacists independent prescribing rights”.

Keep ReadingShow less
New professional liability insurance policy for RPS members launched

The insurance will be provided to members at cost, with no profit made by RPS.

gettyimages

RPS launches professional liability insurance for members

The Royal Pharmaceutical Society (RPS) has launched a new professional liability insurance policy, designed to empower pharmacists to work confidently and deliver high-quality care, knowing they are protected.

Exclusively available to its members, the comprehensive and affordable insurance has been developed in collaboration with global professional services firm Aon.

Keep ReadingShow less
Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less